Skip to content

Clinical trials

Phase 2 Biliary Tract Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Diseases Phase: Phase 2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20141
20191
20201
20214
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mirum Pharmaceuticals, Inc.3
HighTide Therapeutics (Hong Kong) Limited2
Gilead Sciences1
Merck Sharp & Dohme LLC1
National Health Research Institutes, Taiwan1
RenJi Hospital1
United States Naval Medical Center, San Diego1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Diseases10
Bile Duct Diseases7
Cholangitis4
Digestive System Diseases4
Cholangitis, Sclerosing3
Liver Cirrhosis, Biliary2
Liver Diseases2
Abdominal Pain1
Alagille Syndrome1
Biliary Atresia1

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.